- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 14, Issue 2, 2007
Current Medicinal Chemistry - Volume 14, Issue 2, 2007
Volume 14, Issue 2, 2007
-
-
Towards Better Brain Management: Nootropics
Authors: Ruchi Malik, Abhijeet Sangwan, Ruchika Saihgal, Dharam Paul Jindal and Poonam PiplaniThe learning and memory deficits have been recognized as severe and consistent neurological disorders associated with numerous neurodegenerative states. Research in this area has gained momentum only in the recent past after the biochemical and physiological basis of these processes have been understood. A considerable alteration in the neurotransmission is a consistent finding in cognitive disorders. Read More
-
-
-
ATP-Sensitive Potassium Channel Openers and 2,3-Dimethyl-2-Butylamine Derivatives
Authors: Hai Wang, Yuan Tang, Lin Wang, Chao-Liang Long and Ying-Li ZhangATP-sensitive potassium (KATP) channels have important functions through their coupling of cellular energetic networks and their ability to decode metabolic signals, and they are implicated in diseases of many organs. KATP channels are formed by the physical association between the inwardly rectifier potassium channels (Kir6.x) and the regulatory sulfonylurea receptor subunit (SUR), which form a hetero-octameric complex. Di Read More
-
-
-
Left Ventricular Hypertrophy: A Shift in Paradigm
Authors: M.F.L. Meijs, L.J. de Windt, N. de Jonge, M.-J. M. Cramer, M.L. Bots, W.P.Th. M. Mali and P.A. DoevendansObservational studies have identified left ventricular hypertrophy (LVH) as a strong, independent risk factor for the development of heart failure (HF), coronary heart disease and stroke. LVH develops in response to hemodynamic overload. Classical conceptualization has it that LVH would start as an adaptive, beneficial response in order to normalize wall stress. With progression of the disease, deterioration to maladaptive hype Read More
-
-
-
Differentiation of Bone Marrow Stroma-Derived Mesenchymal Cells
Authors: D. Benayahu, U.D. Akavia and I. ShurStem cell biology is a promising, fast-growing field that aims to develop cell-based tools for the treatment of a wide range of diseases. Special attention is paid to bone marrow cells that play a role in the musculoskeletal system. Bone marrow contains hematopoietic stem cells (HSCs) and stromal cells that form the reticular network that supports HSCs formation. Stromal cells also contain mesenchymal stem cells (MSCs) th Read More
-
-
-
Role of Endogenous Inhibitors of Cytokine Signaling in Allergic Asthma
Authors: Hiromasa Inoue, Satoru Fukuyama, Koichiro Matsumoto, Masato Kubo and Akihiko YoshimuraT helper 2 cytokines, including interleukin (IL)-4, IL-5, and IL-13, play an important role in allergic immune disorders, such as bronchial asthma. These cytokines regulate diverse biological functions by binding to receptors at the cell surface to activate complex signal transduction pathways, including the Janus kinase-signal transducer and activator of transcription (JAK-STAT) and the Ras-extracellular signal-regulated kinase (E Read More
-
-
-
miRNAs in the Biology of Cancers and Viral Infections
Authors: Man Lung Yeung, Yamina Bennasser and Kuan-Teh JeangMicroRNAs (miRNAs) are non-coding small RNAs that play important roles in a variety of biological pathways including cellular proliferation and apoptosis. Recent studies have linked the expression of selected miRNAs to carcinogenesis and viral pathogenesis. Here, we will discuss examples of roles served by cellular miRNAs and virus-encoded miRNAs in the development of cancers and viral diseases.
-
-
-
Medicinal Chemistry of Fetal Hemoglobin Inducers for Treatment of β-Thalassemia
Authors: Roberto Gambari and Eitan FibachIn this review we summarize the achievements of medicinal chemistry in the field of pharmacological approaches to the therapy of β-thalassemia using molecules able to stimulate the production of fetal hemoglobin (HbF). We first describe the molecular basis of the pathology and the biochemical rational of using HbF inducers for therapy; we then outlined the in vitro and in vivo experimental systems suitable for scree Read More
-
-
-
Thiol Proteins, Redox Modulation and Parenchymal Lung Disease
Authors: V.L. Kinnula, K. Vuorinen, H. Ilumets, P. Rytila and M. MyllarniemiThe lung is a unique organ in terms of its direct exposure to high levels of oxygen and reactive compounds. Several parenchymal lung diseases (e.g. emphysema associated with smoking and a number of fibrotic lung disorders) have been proposed to be due to the exposure of the lung to exogenous irritants leading to local redox imbalance in the alveolar epithelium. The disease progression of emphysema/chronic obstruct Read More
-
-
-
Possible Effects of Early Treatments of Hsp90 Inhibitors on Preventing the Evolution of Drug Resistance to Other Anti-Cancer Drugs
Authors: Li Xiao, Parsa Rasouli and Douglas M. RudenHsp90 is a chaperone that is critically important for both cancer progression and tumor survival. Hsp90 is an exciting target for anti-cancer drugs because most of the proteins that interact with Hsp90 are known to be in the cell cycle, signaling and chromatin-remodeling pathways. Recent work in fungi has shown that reduction of Hsp90 activity dramatically increases the efficacy of many fungicides. Furthermore, in studies on th Read More
-
-
-
Virostatics: A New Class of Anti-HIV Drugs
Authors: F. Lori, A. Foli, L.M. Kelly and J. LisziewiczIn this review we discuss the features of a new class of antiretroviral combinations, namely “Virostatics”. Virostatics are characterized by the combination of a drug directly inhibiting virus production (viro), and another drug indirectly inhibiting the virus by reducing cellular proliferation (static). In particular, we will focus on the combination of hydroxyurea and didanosine against HIV-1. Hydroxyurea and didanosine syner Read More
-
-
-
Endothelial Dysfunction, Oxidative Stress and Inflammation in Atherosclerosis: Beneficial Effects of Statins
Atherosclerosis and its complications represent the major cause of death in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A [HMGCoA] reductase and consequently inhibitors of cholesterol biosynthesis. Statins have been described as the most potent class of drugs to reduce serum cholesterol levels. In clinical trials, statins are beneficial in primary and secondary prevention of c Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
